NUTX
Nutex HealthANasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-18
Current thesis
Q1 2026 demonstrated substantial revenue, earnings, and operating-cash-flow generation, while high IDR win rates, planned hospital openings, and repurchases provide potential upside if reimbursement economics persist.
Posture
Constructive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.3.
What can break
Delays or cost overruns in the three planned hospital openings and self-development strategy could weaken the growth narrative.
Momentum
96
Value
73
Sentiment
69
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $171.50 · Bull $246.40 · Bear $130.40
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-07-19 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $246.40
Why
Momentum96 · Δ7d -1.4
Value73 · Δ7d +0.3
Sentiment69 · Δ7d +6.4
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Value · See fundamentals
Momentum
96
26% active weight
Current posture
7d trendFlat
Δ7d
-1.4
Δ21d
+2.3
Value
73
39% active weight
Current posture
7d trendFlat
Δ7d
+0.3
Δ21d
+0.2
Sentiment
69
34% active weight
Current posture
7d trendImproving
Δ7d
+6.4
Δ21d
+17.9
Why this grade
Composite grade A. Momentum 95.5 / Value 73.0 / Sentiment 69.1
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$1.12B
Beta
-0.00
Shares Out
6.88M
P/E (TTM)
10.0
P/S (TTM)
1.21
P/FCF (TTM)
9.17
Rev YoY
+2.2%
EPS YoY
+98.2%
Gross Margin
+47.5%
Op Margin
+35.7%
Net Debt
$165.52M
Current Ratio
3.14
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology